The legal industry has been left permanently altered from the pandemic. Five thought leaders provide their exclusive take into what these changes look like from the inside
While WTO member states have expressed general sympathy for the goal to provide broad access to vaccine technology during the pandemic, Germany continues to favour patent protection over compulsory licensing.
The agreed IP waiver is less far-reaching than the original proposal, but underscores how the pandemic has impacted IP politics.
17 June 2022
Despite the close attentions of a tornado and the deadening heatwave that preceded and followed it, delegates and speakers in Chicago were in good form for the final day of this year's event
15 June 2022
BoA President Carl Josefsson also tells IAM that backlog reduction efforts are on track and the organisation is turning its attention toward timeliness of proceedings
27 May 2022
The company claims any infringing uses of its vaccine are insulated from liability under compulsory licensing law
17 May 2022
If compulsory licensing is used in Turkey, it is imperative that the individual requirements of each case are considered. This is especially important when it comes to facilitating access to medical treatments for covid-19.
30 March 2022
Several new legal actions have been launched by lipid nanoparticle technology owners
28 March 2022
There are reports of a compromise deal agreeed by the US, EU, India and South Africa, but no official confirmation
16 March 2022
Petro Terblanche speaks to IAM about the mRNA innovator’s expanded IP commitment
14 March 2022
Arbutus Biopharma and Genevant Sciences have filed suit against the vaccine innovator
07 March 2022
In a closely watched case, the Supreme Court has upheld the Civil Code’s prioritising of people’s lives and health during the covid-19 pandemic, over profits lost to patent owners
23 February 2022
Unlock unlimited access to all IAM content
